Volume Spike Investor

Pharmacyclics (NASDAQ: PCYC) is a micro-cap biotech that may get overlooked by most because of its size and share price. The stock is surging on a 19% gain to $1.25 today on positive data from Phase I/II non-Hodgkins lymphoma presented at the International Conference on Malignant Lymphoma. This is a 5-times normal trading volume day [...]